The long-term goal is to understand the mechanism of catalysis by catalytic antibodies (abzymes). Many reactions differing in complexity and importance have now been catalyzed. The question of whether antibodies use the same or different mechanisms, kinetics, rate enhancement steps or similar reaction profiles as enzymes can be addressed by the study of their three-dimensional structure. Our goal is to determine the X-ray structures of various catalytic Fabs in the presence and absence of their substrate or transition state analogues. It is our intent to understand the role of desolvation, acid-base catalysis, strain, proximity effects and stabilization of transition states in their catalytic mechanism. The question of how to redesign and improve abzymes by site-directed mutagenesis, introduction of functional groups such as cofactors, metals and unnatural amino acids, or by alteration of substrate or transition state design will be addressed in conjunction with the X-ray structural studies. The immediate objectives are to understand the following reactions. 1. Antibody Catalysis of a Claisen Rearrangement 2. Antibody Catalysis of a Diels-Alder Cylcoaddition 3. Antibody Catalysis of a Decarboxylation 4. Antibody Catalysis of an Amide/Ester Hydrolysis 5. Antibody Catalysis of a Transesterification Reaction 6. Antibody Catalysis of Disfavored Transformations 7. Evolution of Antibody Catalysis 8. Antibody Catalysis of Other Transformations The methods used to determine the X-ray structures will be conventional molecular replacement and standard refinement protocols. The design of stable ligands and the use of cryocrystallography will be used to collect high resolution data on relevant complexes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA027489-19
Application #
6269100
Study Section
Project Start
1998-03-01
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
19
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Zhu, Xueyong; Tanaka, Fujie; Lerner, Richard A et al. (2009) Direct observation of an enamine intermediate in amine catalysis. J Am Chem Soc 131:18206-7
Kamikubo, Yuichi; Kroon, Gerard; Curriden, Scott A et al. (2006) The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule. Biochemistry 45:3297-306
Zhu, Xueyong; Wentworth Jr, Paul; Kyle, Robert A et al. (2006) Cofactor-containing antibodies: crystal structure of the original yellow antibody. Proc Natl Acad Sci U S A 103:3581-5
Steiner, Derek D; Mase, Nobuyuki; Barbas 3rd, Carlos F (2005) Direct asymmetric alpha-fluorination of aldehydes. Angew Chem Int Ed Engl 44:3706-10
Suri, Jeff T; Ramachary, Dhevalapally B; Barbas 3rd, Carlos F (2005) Mimicking dihydroxy acetone phosphate-utilizing aldolases through organocatalysis: a facile route to carbohydrates and aminosugars. Org Lett 7:1383-5
Chowdari, Naidu S; Barbas 3rd, Carlos F (2005) Total synthesis of LFA-1 antagonist BIRT-377 via organocatalytic asymmetric construction of a quaternary stereocenter. Org Lett 7:867-70
Ramachary, Dhevalapally B; Barbas 3rd, Carlos F (2005) Direct amino acid-catalyzed asymmetric desymmetrization of meso-compounds: tandem aminoxylation/O-N bond heterolysis reactions. Org Lett 7:1577-80
Suri, Jeff T; Steiner, Derek D; Barbas 3rd, Carlos F (2005) Organocatalytic enantioselective synthesis of metabotropic glutamate receptor ligands. Org Lett 7:3885-8
Tanaka, Fujie; Fuller, Roberta; Barbas 3rd, Carlos F (2005) Development of small designer aldolase enzymes: catalytic activity, folding, and substrate specificity. Biochemistry 44:7583-92
Mase, Nobuyuki; Thayumanavan, Rajeswari; Tanaka, Fujie et al. (2004) Direct asymmetric organocatalytic Michael reactions of alpha,alpha-disubstituted aldehydes with beta-nitrostyrenes for the synthesis of quaternary carbon-containing products. Org Lett 6:2527-30

Showing the most recent 10 out of 155 publications